patent/CL-2012002541-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2012002541-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
filingDate	2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b29fbd4963dc6e08a3fafc809bcdc939 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8448732ce280b597a98e15053d5272e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b26dc23f2d272f8797b0e3750fa13a7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c725269abc2b4a95882af617e9e5452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b36a712b5cc604743111b05948fb23f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b15ac09fe42a689adf022f7c01c408
publicationDate	2013-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CL-2012002541-A1
titleOfInvention	Crystalline compound hydrate of agomelatine hydrobromide; compound preparation method; pharmaceutical composition; use of the compound to treat sleep disorders, stress, anxiety, major depression, schizophrenia, among others.
abstract	Crystalline compound hydrate of agomelatine hydrobromide; compound preparation method; pharmaceutical composition; use of the compound to treat sleep disorders, stress, anxiety, major depression, schizophrenia, among others.
priorityDate	2010-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82148 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480088

Total number of triples: 33.